VALPOSAFE 500CR
COMPOSITION - Sodium Valproate 333 mg + Valproic Acid 145 mg (Controlled Release) Tablets
DESCRIPTION - VALPOSAFE 500 CR is a controlled-release anticonvulsant formulation that enhances gamma-aminobutyric acid (GABA) levels in the brain, increasing inhibitory neurotransmission and stabilizing neuronal firing. This helps suppress abnormal electrical activity responsible for seizures. The controlled-release mechanism ensures sustained drug levels, improving seizure control and reducing dosing frequency.
Uses
- Epilepsy
- Generalized tonic-clonic seizures
- Partial seizures
- Neurological seizure disorders
- Bipolar disorder (mood stabilization)
Side Effects
- Nausea or vomiting
- Drowsiness
- Weight gain
- Tremors
- Hair thinning (temporary)
Precautions / Other Important Details
Use cautiously in patients with liver impairment
Contraindicated in pregnancy due to teratogenic risk
- Regular monitoring of platelet count may be required
